These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 3797683
1. Extraneural cholinergic markers in Alzheimer's and Parkinson's disease. Adem A, Nordberg A, Bucht G, Winblad B. Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):247-57. PubMed ID: 3797683 [Abstract] [Full Text] [Related]
2. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. Perry EK, Smith CJ, Court JA, Perry RH. J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197 [Abstract] [Full Text] [Related]
3. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK. Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614 [Abstract] [Full Text] [Related]
4. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. Perry EK, Perry RH, Smith CJ, Dick DJ, Candy JM, Edwardson JA, Fairbairn A, Blessed G. J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):806-9. PubMed ID: 2956364 [Abstract] [Full Text] [Related]
5. A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Rinne JO, Myllykylä T, Lönnberg P, Marjamäki P. Brain Res; 1991 Apr 26; 547(1):167-70. PubMed ID: 1860068 [Abstract] [Full Text] [Related]
6. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Whitehouse PJ, Martino AM, Wagster MV, Price DL, Mayeux R, Atack JR, Kellar KJ. Neurology; 1988 May 26; 38(5):720-3. PubMed ID: 3362368 [Abstract] [Full Text] [Related]
7. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. Nordberg A, Alafuzoff I, Winblad B. J Neurosci Res; 1992 Jan 26; 31(1):103-11. PubMed ID: 1613816 [Abstract] [Full Text] [Related]
9. Changes of muscarinic cholinergic binding by lymphocytes in Parkinson's disease with and without dementia. Rabey JM, Grynberg E, Graff E. Ann Neurol; 1991 Dec 26; 30(6):847-50. PubMed ID: 1789698 [Abstract] [Full Text] [Related]
12. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases. Perry RH, Perry EK, Smith CJ, Xuereb JH, Irving D, Whitford CA, Candy JM, Cross AJ. J Neural Transm Suppl; 1987 Dec 26; 24():131-6. PubMed ID: 2824687 [Abstract] [Full Text] [Related]
19. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation]. Dubois B, Hauw JJ, Ruberg M, Serdaru M, Javoy-Agid F, Agid Y. Rev Neurol (Paris); 1985 Dec 26; 141(3):184-93. PubMed ID: 4001706 [Abstract] [Full Text] [Related]
20. Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Nordberg A, Winblad B. Neurosci Lett; 1986 Dec 03; 72(1):115-9. PubMed ID: 3808458 [Abstract] [Full Text] [Related] Page: [Next] [New Search]